1 million shares changing hands, page-3

I would say that the recent developments have attracted some speculators into the stock. As events unfold the true value of Biota's pipeline should be revealed. Come mid-year we should see LANI phase III and HRV phase II results, some developments for RSV would also be welcomed. Relenza royalties are also set to increase with Japanese sales but I feel the pipe is what speculators are after. Biota has seen some dramatic spikes in it's history... can it happen again on the back of the current pipe?